NYSE:CVS - CVS Health Stock Price, Price Target & More

$68.69 +0.96 (+1.42 %)
(As of 04/26/2018 04:00 PM ET)
Previous Close$68.69
Today's Range$67.70 - $69.3750
52-Week Range$60.14 - $84.00
Volume10.66 million shs
Average Volume8.61 million shs
Market Capitalization$67.57 billion
P/E Ratio11.64
Dividend Yield3.00%
Beta1.05

About CVS Health (NYSE:CVS)

CVS Health logoCVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:CVS
CUSIP12665010
Phone401-765-1500

Debt

Debt-to-Equity Ratio0.59%
Current Ratio1.02%
Quick Ratio0.52%

Price-To-Earnings

Trailing P/E Ratio11.64
Forward P/E Ratio10.87
P/E Growth1.13

Sales & Book Value

Annual Sales$184.77 billion
Price / Sales0.38
Cash Flow$8.8632 per share
Price / Cash7.75
Book Value$37.21 per share
Price / Book1.85

Profitability

EPS (Most Recent Fiscal Year)$5.90
Net Income$6.62 billion
Net Margins3.58%
Return on Equity17.21%
Return on Assets6.48%

Miscellaneous

Employees246,000
Outstanding Shares1,014,530,000

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health declared a quarterly dividend on Tuesday, March 13th. Shareholders of record on Monday, April 23rd will be given a dividend of $0.50 per share on Thursday, May 3rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.91%. The ex-dividend date is Friday, April 20th. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health (NYSE:CVS) announced its earnings results on Thursday, February, 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.88 by $0.04. The pharmacy operator had revenue of $48.39 billion for the quarter, compared to analyst estimates of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.71 EPS. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for CVS Health.

What price target have analysts set for CVS?

20 equities research analysts have issued twelve-month target prices for CVS Health's shares. Their predictions range from $73.00 to $99.00. On average, they anticipate CVS Health's stock price to reach $87.2353 in the next twelve months. View Analyst Ratings for CVS Health.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest during the month of April. As of April 13th, there was short interest totalling 43,345,137 shares, an increase of 3.2% from the March 30th total of 41,995,032 shares. Based on an average trading volume of 6,785,792 shares, the days-to-cover ratio is presently 6.4 days. Approximately 4.3% of the shares of the stock are short sold.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 62)
  • Mr. David M. Denton, Exec. VP & CFO (Age 53)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 62)
  • Mr. Thomas Michael Moriarty, Exec. VP, Gen. Counsel and Chief of Policy & External Affairs Officer (Age 54)
  • Ms. Eva C. Boratto, Exec. VP, Controller & Chief Accounting Officer (Age 51)

Has CVS Health been receiving favorable news coverage?

Press coverage about CVS stock has been trending somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. CVS Health earned a daily sentiment score of 0.11 on Accern's scale. They also gave media coverage about the pharmacy operator an impact score of 47.45 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $68.69.

How big of a company is CVS Health?

CVS Health has a market capitalization of $67.57 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (CVS)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  940 (Vote Outperform)
Underperform Votes:  435 (Vote Underperform)
Total Votes:  1,375
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CVS Health (NYSE:CVS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
20 Wall Street analysts have issued ratings and price targets for CVS Health in the last 12 months. Their average twelve-month price target is $87.2353, suggesting that the stock has a possible upside of 27.00%. The high price target for CVS is $99.00 and the low price target for CVS is $73.00. There are currently 6 hold ratings, 12 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.802.762.64
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
2 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
2 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
2 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $87.2353$87.5789$88.0335$87.93
Price Target Upside: 27.00% upside28.36% upside9.44% upside19.94% upside

CVS Health (NYSE:CVS) Consensus Price Target History

Price Target History for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/11/2018Bank of AmericaLower Price TargetBuy -> Buy$91.00 -> $88.00LowView Rating Details
4/10/2018Leerink SwannSet Price TargetBuy$85.00LowView Rating Details
2/13/2018CitigroupSet Price TargetNeutral -> Neutral$80.00 -> $77.00LowView Rating Details
2/9/2018Robert W. BairdLower Price TargetNeutral -> Neutral$85.00 -> $80.00LowView Rating Details
2/9/2018Needham & Company LLCSet Price TargetStrong-Buy -> Buy$100.00 -> $98.00MediumView Rating Details
2/8/2018Royal Bank of CanadaSet Price TargetBuy$89.00MediumView Rating Details
1/24/2018MizuhoSet Price TargetBuy$95.00LowView Rating Details
1/18/2018CowenReiterated RatingOutperform$81.00 -> $99.00LowView Rating Details
1/5/2018SunTrust BanksBoost Price TargetBuy$90.00HighView Rating Details
1/5/2018Morgan StanleyUpgradeEqual Weight -> Overweight$88.00HighView Rating Details
1/4/2018Raymond JamesUpgradeOutperform -> Strong-Buy$90.00HighView Rating Details
1/4/2018UBSUpgradeOutperform -> Strong-BuyHighView Rating Details
12/26/2017Tigress FinancialReiterated RatingBuyLowView Rating Details
12/5/2017Deutsche BankReiterated RatingBuy -> HoldMediumView Rating Details
12/4/2017Jefferies GroupSet Price TargetHold$76.00MediumView Rating Details
12/4/2017Loop CapitalSet Price TargetHold$73.00MediumView Rating Details
10/9/2017OppenheimerReiterated RatingBuy$95.00N/AView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform -> Market Perform$89.00 -> $82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016BarclaysReiterated RatingBuy$85.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

CVS Health (NYSE:CVS) Earnings History and Estimates Chart

Earnings by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Earnings Estimates

2018 EPS Consensus Estimate: $6.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$1.10$1.49$1.29
Q2 20185$1.43$1.63$1.56
Q3 20184$1.32$1.91$1.62
Q4 20184$1.93$1.99$1.97
Q1 20192$1.06$1.24$1.15
Q2 20192$1.26$1.59$1.43
Q3 20191$1.43$1.43$1.43

CVS Health (NYSE CVS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$1.34N/AView Earnings Details
2/8/2018Q4 2017$1.88$1.92$47.5388 billion$48.3850 billionViewListenView Earnings Details
11/6/2017Q3 2017$1.49$1.50$46.1740 billion$46.1810 billionViewN/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.3553 billion$45.6850 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.1030$1.17$44.2025 billion$44.5140 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.0880 billion$30.2270 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
2/8/2012Q4 2011$0.89$0.89ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
11/3/2010Q3 2010$0.64$0.65ViewN/AView Earnings Details
7/28/2010Q2 2010$0.68$0.65ViewN/AView Earnings Details
5/4/2010Q1 2010$0.58$0.60ViewN/AView Earnings Details
2/8/2010Q4 2009$0.78$0.79ViewN/AView Earnings Details
11/5/2009Q3 2009$0.64$0.65ViewN/AView Earnings Details
8/4/2009Q2 2009$0.64$0.65ViewN/AView Earnings Details
5/5/2009Q1 2009$0.54$0.55ViewN/AView Earnings Details
2/19/2009Q4 2008$0.69$0.70ViewN/AView Earnings Details
10/30/2008Q3 2008$0.59$0.60ViewN/AView Earnings Details
7/31/2008Q2 2008$0.60$0.60ViewN/AView Earnings Details
5/1/2008Q1 2008$0.54$0.55ViewN/AView Earnings Details
1/31/2008Q4 2007$0.55$0.58ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

CVS Health (NYSE:CVS) Dividend Information

CVS Health pays an annual dividend of $2.00 per share, with a dividend yield of 2.91%. CVS's next quarterly dividend payment will be made on Thursday, May 3. The company has grown its dividend for the last 10 consecutive years and is increasing its dividend by an average of 22.10% each year. CVS Health pays out 33.90% of its earnings out as a dividend.
Next Dividend:5/3/2018
Annual Dividend:$2.00
Dividend Yield:2.91%
Dividend Growth:22.10% (3 Year Average)
Payout Ratio:33.90% (Trailing 12 Months of Earnings)
31.65% (Based on This Year's Estimates)
29.63% (Based on Next Year's Estimates)
Track Record:10 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/13/2018quarterly$0.502.9655990510083%4/20/20184/23/20185/3/2018
12/29/2017quarterly$0.502.72%1/23/20181/24/20182/2/2018
9/19/2017quarterly$0.502.48%10/23/201710/24/201711/3/2017
7/6/2017quarterly$0.502.54%7/20/20177/24/20178/3/2017
3/2/2017quarterly$0.502.47%4/19/20174/21/20175/1/2017
12/22/2016quarterly$0.502.54%1/20/20171/24/20172/2/2017
9/22/2016quarterly$0.42501.88%10/20/201610/24/201611/3/2016
7/6/2016quarterly$0.42501.78%7/19/20167/21/20168/1/2016
3/2/2016quarterly$0.42501.71%4/20/20164/22/20165/2/2016
12/16/2015quarterly$0.42501.79%1/20/20161/22/20162/2/2016
10/1/2015quarterly$0.351.41%10/20/201510/22/201511/2/2015
7/8/2015quarterly$0.351.32%7/21/20157/23/20158/3/2015
3/4/2015quarterly$0.351.35%4/22/20154/24/20155/4/2015
12/17/2014quarterly$0.351.49%1/20/20151/22/20152/2/2015
9/24/2014quarterly$0.27501.38%10/21/201410/23/201411/3/2014
7/10/2014quarterly$0.27501.43%7/17/20147/21/20148/1/2014
3/6/2014quarterly$0.27501.5%4/17/20144/22/20145/2/2014
12/18/2013quarterly$0.27501.57%1/21/20141/23/20142/3/2014
9/25/2013quarterly$0.22501.55%10/17/201310/21/201311/1/2013
7/10/2013quarterly$0.22501.48%7/18/20137/22/20138/2/2013
3/6/2013quarterly$0.22501.73%4/19/20134/23/20135/3/2013
12/13/2012quarterly$0.22501.83%1/22/20131/24/20132/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

CVS Health (NYSE CVS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 84.01%
Insider Trading History for CVS Health (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/16/2018Helena FoulkesEVPSell19,965$71.04$1,418,313.6065,072View SEC Filing  
12/21/2017Lisa BisacciaEVPSell29,445$75.00$2,208,375.0015,556View SEC Filing  
10/2/2017Thomas M MoriartyEVPSell20,547$81.17$1,667,799.9943,178View SEC Filing  
9/18/2017Jonathan C RobertsCOOSell85,743$83.14$7,128,673.02119,555View SEC Filing  
9/15/2017Helena FoulkesEVPSell39,340$81.88$3,221,159.2084,337View SEC Filing  
9/13/2017Larry J MerloInsiderSell241,150$83.07$20,032,330.50299,255View SEC Filing  
9/11/2017David M DentonCFOSell237,078$79.65$18,883,262.70141,096View SEC Filing  
9/11/2017Thomas M MoriartyEVPSell90,267$79.61$7,186,155.8770,102View SEC Filing  
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.003,258View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.0059,301View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.3659,300View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00176,983View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.7794,309View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.4041,614View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.6022,801View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24250,335View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.0089,955View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00280,381View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.0069,601View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.0042,048View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00261,287View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.3075,315View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02561,059View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00161,613View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.0043,858View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.086,998View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.1156,187View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.5085,869View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52219,871View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.1240,563View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00408,649View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.0027,233View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.0756,187View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.5019,448View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.007,897View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.203,128View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CVS Health (NYSE CVS) News Headlines

Source:
DateHeadline
CVS Health Underscores Commitment to Safe Medication Disposal Ahead of National Prescription Drug Take-Back Day on April 28CVS Health Underscores Commitment to Safe Medication Disposal Ahead of National Prescription Drug Take-Back Day on April 28
finance.yahoo.com - April 26 at 3:03 PM
See what the IHS Markit Score report has to say about CVS Health Corp.See what the IHS Markit Score report has to say about CVS Health Corp.
finance.yahoo.com - April 26 at 3:03 PM
Beauty isnt airbrushed in new CVS campaignBeauty isn't airbrushed in new CVS campaign
www.bizjournals.com - April 25 at 3:10 PM
Contrasting Diplomat Pharmacy (DPLO) & CVS Health (CVS)Contrasting Diplomat Pharmacy (DPLO) & CVS Health (CVS)
www.americanbankingnews.com - April 25 at 7:44 AM
BRIEF-CVS Health Corp CEOs 2017 Compensation Was $12.25 MillionBRIEF-CVS Health Corp CEO's 2017 Compensation Was $12.25 Million
www.reuters.com - April 25 at 5:02 AM
CVS Health (CVS) Set to Announce Quarterly Earnings on WednesdayCVS Health (CVS) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 25 at 2:56 AM
Should You Buy CVS Health Corporation (NYSE:CVS)?Should You Buy CVS Health Corporation (NYSE:CVS)?
finance.yahoo.com - April 24 at 3:11 PM
Factors Setting Stage For CVS Healths Q1 EarningsFactors Setting Stage For CVS Health's Q1 Earnings
feeds.benzinga.com - April 24 at 12:49 PM
Factors Setting Stage for CVS Healths (CVS) Q1 EarningsFactors Setting Stage for CVS Health's (CVS) Q1 Earnings
finance.yahoo.com - April 24 at 5:14 AM
Factors Setting Stage for CVS Health's (CVS) Q1 EarningsFactors Setting Stage for CVS Health's (CVS) Q1 Earnings
finance.yahoo.com - April 24 at 5:14 AM
Glenviews Robbins says talk of Amazons entering pharma is overblownGlenview's Robbins says talk of Amazon's entering pharma is overblown
finance.yahoo.com - April 24 at 5:14 AM
Humana, private-equity firms to buy hospice operator Curo Health for $1.4 billionHumana, private-equity firms to buy hospice operator Curo Health for $1.4 billion
www.cnbc.com - April 23 at 3:04 PM
You can get rid of your unused medications at these drugstoresYou can get rid of your unused medications at these drugstores
finance.yahoo.com - April 23 at 3:04 PM
Retail Clinics Are Not the Solution to Health CareRetail Clinics Are Not the Solution to Health Care
www.nytimes.com - April 23 at 5:43 AM
Longs Drugs opening Makaha store, preps to start on new Nanakuli shopping centerLongs Drugs opening Makaha store, preps to start on new Nanakuli shopping center
finance.yahoo.com - April 21 at 5:02 AM
CVS Pharmacy Offering Hepatitis A Vaccine to Kentuckians Following an Increase in Confirmed Cases of the VirusCVS Pharmacy Offering Hepatitis A Vaccine to Kentuckians Following an Increase in Confirmed Cases of the Virus
finance.yahoo.com - April 20 at 3:10 PM
CVS reveals beauty campaign with unretouched imagesCVS reveals beauty campaign with unretouched images
abcnews.go.com - April 20 at 3:10 PM
Shift To ACAs Bronze Plans Could Boost CVS, Walgreens And Walmart Retail ClinicsShift To ACA's Bronze Plans Could Boost CVS, Walgreens And Walmart Retail Clinics
www.forbes.com - April 20 at 3:10 PM
Shift To ACAs Bronze Plans Boosts CVS, Walgreens And Walmart Retail ClinicsShift To ACA's Bronze Plans Boosts CVS, Walgreens And Walmart Retail Clinics
finance.yahoo.com - April 20 at 3:10 PM
Leerink Swann Analysts Give CVS Health (CVS) a $90.00 Price TargetLeerink Swann Analysts Give CVS Health (CVS) a $90.00 Price Target
www.americanbankingnews.com - April 20 at 3:01 PM
CVS Health Corporation To Hold First Quarter 2018 Conference CallCVS Health Corporation To Hold First Quarter 2018 Conference Call
www.prnewswire.com - April 20 at 12:17 PM
Phoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans ...Phoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans ...
www.prnewswire.com - April 20 at 5:15 AM
For Now, Hospitals Hang On Despite CVS, Optum And Walmart ThreatsFor Now, Hospitals Hang On Despite CVS, Optum And Walmart Threats
finance.yahoo.com - April 19 at 3:11 PM
EX-Dividend Schedule: CVS Health Has a Dividend Yield of 3.03%; Will Trade Ex-Dividend on April 20, 2018EX-Dividend Schedule: CVS Health Has a Dividend Yield of 3.03%; Will Trade Ex-Dividend on April 20, 2018
finance.yahoo.com - April 19 at 3:11 PM
CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Ohio to Help Combat Opioid AbuseCVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Ohio to Help Combat Opioid Abuse
finance.yahoo.com - April 19 at 3:11 PM
CVS Pharmacy Launches First Campaign Featuring Unaltered Beauty ImageryCVS Pharmacy Launches First Campaign Featuring Unaltered Beauty Imagery
finance.yahoo.com - April 19 at 3:11 PM
Ex-Dividend Reminder: CVS Health, Interdigital and GEO GroupEx-Dividend Reminder: CVS Health, Interdigital and GEO Group
www.nasdaq.com - April 18 at 3:11 PM
Phoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans Access to Health CarePhoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans' Access to Health Care
finance.yahoo.com - April 18 at 3:11 PM
Cardinal Health stock up on news that Amazon will stay away from shipping drugsCardinal Health stock up on news that Amazon will stay away from shipping drugs
www.bizjournals.com - April 18 at 5:18 AM
Aetna to reorganize ahead of CVS dealAetna to reorganize ahead of CVS deal
finance.yahoo.com - April 18 at 5:18 AM
Aetna to hire 250 as part of 'innovation hub' expansion in WellesleyAetna to hire 250 as part of 'innovation hub' expansion in Wellesley
finance.yahoo.com - April 18 at 5:18 AM
Why Did CVS Move Higher on April 16?Why Did CVS Move Higher on April 16?
finance.yahoo.com - April 17 at 3:15 PM
Pharmacy Stocks Rise on News Amazon is Backing OffPharmacy Stocks Rise on News Amazon is Backing Off
finance.yahoo.com - April 17 at 3:15 PM
Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18
finance.yahoo.com - April 17 at 3:15 PM
Moodys: Healthcare Quarterly looks at credit impact of planned mergers in US healthcareMoody's: Healthcare Quarterly looks at credit impact of planned mergers in US healthcare
finance.yahoo.com - April 17 at 3:15 PM
Pharmacy, health company stocks spike with news that Amazon will stay away from shipping drugsPharmacy, health company stocks spike with news that Amazon will stay away from shipping drugs
www.bizjournals.com - April 17 at 6:59 AM
New retail chief at CVS HealthNew retail chief at CVS Health
seekingalpha.com - April 17 at 6:59 AM
Why Are Walgreens and CVS Shares Surging Today?Why Are Walgreens and CVS Shares Surging Today?
www.zacks.com - April 17 at 6:59 AM
CVS Rallies After Amazon ReportCVS Rallies After Amazon Report
www.bloomberg.com - April 17 at 6:59 AM
CVS Health (CVS) Stock Rating Lowered by BidaskClubCVS Health (CVS) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 16 at 7:00 PM
Thinking about buying stock in Alkermes, Bank of America, CVS Health Corp, The Goldman Sachs Group and Tesla MotorsThinking about buying stock in Alkermes, Bank of America, CVS Health Corp, The Goldman Sachs Group and Tesla Motors
www.bizjournals.com - April 16 at 3:19 PM
Industry Moves: HBC Taps Another Woman From CVS for a Top RoleIndustry Moves: HBC Taps Another Woman From CVS for a Top Role
www.msn.com - April 16 at 3:19 PM
Amazon shelves plans to sell, distribute drugs to hospitals - CNBCAmazon shelves plans to sell, distribute drugs to hospitals - CNBC
finance.yahoo.com - April 16 at 3:19 PM
CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in West Virginia to Help Combat Opioid AbuseCVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in West Virginia to Help Combat Opioid Abuse
finance.yahoo.com - April 16 at 3:19 PM
Drug distributor and drugstore stocks rally after Amazon shelves plan to sell to hospitalsDrug distributor and drugstore stocks rally after Amazon shelves plan to sell to hospitals
finance.yahoo.com - April 16 at 3:19 PM
CVS stock spikes with news that Amazon will stay away from shipping drugsCVS stock spikes with news that Amazon will stay away from shipping drugs
finance.yahoo.com - April 16 at 3:19 PM
CVS Health Appoints Kevin Hourican as President of CVS PharmacyCVS Health Appoints Kevin Hourican as President of CVS Pharmacy
finance.yahoo.com - April 16 at 3:19 PM
Amazon Report Sends CVS, Walgreens, These Drug Distributors SoaringAmazon Report Sends CVS, Walgreens, These Drug Distributors Soaring
finance.yahoo.com - April 16 at 3:19 PM
Drug players’ shares spike on report that Amazon no longer plans to sell pharmaceuticalsDrug players’ shares spike on report that Amazon no longer plans to sell pharmaceuticals
finance.yahoo.com - April 16 at 3:19 PM
CVS Health Teams Up with Job Corps to Enhance Workforce Development Opportunities for Aspiring Pharmacy TechniciansCVS Health Teams Up with Job Corps to Enhance Workforce Development Opportunities for Aspiring Pharmacy Technicians
www.prnewswire.com - April 16 at 8:06 AM

SEC Filings

CVS Health (NYSE:CVS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CVS Health (NYSE:CVS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CVS Health (NYSE CVS) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.